Prevalence of bacterial co-infections among patients admitted with COVID-19
DOI:
https://doi.org/10.1996/pjcm.v28i4.759Keywords:
SARS-CoV-2, COVID-19, Antibiotic Resistance, Bacterial Infections, Respiratory DiseasesAbstract
Background: A respiratory disease with variant SARS-CoV-2, which was later names as corona virus was first detected in city of China, Wuhan in the end of the year 2019 that rapidly transmitted across the world. The disease could turn into a serious conditions in some of the patients who requires hospital care with mechanical ventilation support in nearly 5–15% of cases. Approximately 10% of the infected patients required hospital admission due to thrombotic events, developing pneumonia or co-infections. Objective: Objective of the present study was to asceratin the pattern of bacterial co-infection in patients admitted with COVID-19 in a tertiary care hospital in Karachi, Pakistan. Methodology: This was Prospective, observational study conducted at Ziauudin Hospital Karachi during April 2021- June 2022. This study included COVID-19 patients those were admitted with COVID-19 in a tertiary care hospital in Karachi, Pakistan. All of the patients were investigated after confirmation of COVID-19 through real-time polymerase chain reaction test. Detailed history including comorbidity, smoking status and presenting symptoms was noted at the time of hospital admission. Blood and urine specimens were taken according to the hospital protocol. Results: Total 99 patients were studied with mean age of 60.7 ± 15 years. Majority of the admitted patients were males (43.5%), non-smokers (85.9%) and had comorbidity (76.8%). More than half of the patients had co-infections (77.8%) with total 116 detected microorganisms. Out of 77.8% patients having infections other than SARS-CoV-2, the most frequent organisms isolated were, Candida albicans (44.2%), Escherichia coli (41.6%), Coagulase negative staphlylococcus (35.1%), Klebsiella species (7.8%), Proteus mirabilis (5.2%), Group D streptococcus (5.2%), Enterobacter (2.6%), Pseudomonas aeruginosa (2.6%), Acinetobacter (2.6%), Baccilus (1.3%), Enterococuss species (1.3%), Stenotrophomonas Maltophilia and Staphylococcus Aureus. Conclusion: The present study analyzed that in addition to gram positive and gram-negative bacterial infections, fungal infections were also coexisting in COVID-19 patients in Karachi Pakistan. Patients with increasing age were more prone to have co-infections. Key words: SARS-CoV-2; COVID-19; Antibiotic resistance; Bacterial infections; Respiratory diseasesReferences
Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiol. 2020;296(2):E15-25.
Möhlenkamp S, Thiele H. Ventilation of COVID-19 patients in intensive care units. Herz. 2020;45(4):329-31.
Garcia-Vidal C, Moreno-García E, Hernández-Meneses M, Puerta-Alcalde P, Chumbita M, Garcia-Pouton N, et al. Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019. Clin Infect Dis. 2022;74(1):127-32.
Gupta RK, George R, Nguyen-Van-Tam JS. Bacterial pneumonia and pandemic influenza planning. Emerg Infect Dis. 2008;14(8):1187-92.
Rice TW, Rubinson L, Uyeki TM, Vaughn FL, John BB, Miller RR, 3rd, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med. 2012;40(5):1487-98.
Cao J, Hu X, Cheng W, Yu L, Tu WJ. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019. Intensive Care Med. 2020;46(5):851-3.
Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol. 2020;127:104364.
Yue H, Zhang M, Xing L, Wang K, Rao X, Liu H, et al. The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak. J Med Virol. 2020;92(11):2870-3.
Sreenath K, Batra P, Vinayaraj EV, Bhatia R, SaiKiran K, Singh V, et al. Coinfections with Other Respiratory Pathogens among Patients with COVID-19. Microbiol Spectr. 2021;9(1):e0016321.
Khurana S, Singh P, Sharad N, Kiro VV, Rastogi N, Lathwal A, et al. Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: Implication on antimicrobial resistance. Indian J Med Microbiol. 2021;39(2):147-53.
Contou D, Claudinon A, Pajot O, Micaëlo M, Longuet Flandre P, Dubert M, et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care. 2020;10(1):119.
Saeed NK, Al-Khawaja S, Alsalman J, Almusawi S, Albalooshi NA, Al-Biltagi M. Bacterial co-infection in patients with SARS-CoV-2 in the Kingdom of Bahrain. World J Virol. 2021;10(4):168-81.
Coşkun AS, Durmaz Ş. Fungal Infections in COVID-19 Intensive Care Patients. Pol J Microbiol. 2021;70(3):395-400.
Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020;26(10):1395-9.
Alqahtani A, Alamer E, Mir M, Alasmari A, Alshahrani MM, Asiri M, et al. Bacterial Coinfections Increase Mortality of Severely Ill COVID-19 Patients in Saudi Arabia. International journal of environmental research and public health. 2022;19(4):2424.
Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020;53(4):505-12.
Shafran N, Shafran I, Ben-Zvi H, Sofer S, Sheena L, Krause I, et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Sci Rep. 2021;11(1):12703.
He S, Liu W, Jiang M, Huang P, Xiang Z, Deng D, et al. Clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection: A multi-center study. PLoS One. 2021;16(4):e0249668.
Silva DL, Lima CM, Magalhães VCR, Baltazar LM, Peres NTA, Caligiorne RB, et al. Fungal and bacterial coinfections increase mortality of severely ill COVID-19 patients. J Hosp Infect. 2021;113:145-54.
Bashir A, Abdullah MS, Momin NR, Chong PL, Asli R, Ivan BM, et al. Prevalence of primary bacterial co-infections among patients with COVID-19 in Brunei Darussalam. Western Pac Surveill Response J. 2021;12(3):65-70.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan Journal of Chest Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.